Kailera Therapeutics Files for US IPO to Fund Obesity Drugs
Kailera Therapeutics Inc. filed for a US initial public offering to help fund the development of its pipeline of obesity drugs.
By Anthony Hughes ยท Bloomberg
Kailera Therapeutics Inc. filed for a US initial public offering to help fund the development of its pipeline of obesity drugs.